Drugs / Celgosivir

Trials 8 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00002329 HIV infectious disease Hoechst Marion Roussel Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT01619969 Jul 2012 → Mar 2013 dengue disease Singapore General Hospital Completed No outcome recorded
Phase 26 trials
Phase 2 NCT00332176 Jun 2006 → Dec 2008 chronic hepatitis C virus infection BioWest Therapeutics Inc Unknown No outcome recorded
Phase 2 NCT00292084 Feb 2006 → Oct 2007 chronic hepatitis C virus infection BioWest Therapeutics Inc Completed No outcome recorded
Phase 2 NCT00217139 Sep 2005 → Sep 2006 chronic hepatitis C virus infection BioWest Therapeutics Inc Completed No outcome recorded
Phase 2 NCT00157534 Oct 2004 → Aug 2005 chronic hepatitis C virus infection BioWest Therapeutics Inc Completed No outcome recorded
Phase 2 NCT00002150 HIV infectious disease Hoechst Marion Roussel Completed No outcome recorded
Phase 2 NCT00002151 HIV infectious disease Hoechst Marion Roussel Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02569827 Comparator Dec 2018 → Aug 2019 dengue disease Singapore General Hospital Withdrawn No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as Celgosivir ClinicalTrials.gov intervention name — accepted as the source's own label NCT00292084
8

NCT00002151

NCT00002150

NCT02569827

NCT01619969

NCT00002329

NCT00217139

NCT00157534

NCT00332176

Known as Celgosivir hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL2110737
Known as CELGOSIVIR HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL2110737
Known as MDL 28,574A ChEMBL registry synonym — accepted as the source's own label CHEMBL2110737
Action Inhibit “We tested the α-glucosidase inhibitor celgosivir as a treatment for acute dengue fever.” PMID 24877997 May 2014
Modality Small molecule CHEMBL2110737
Route Oral “administered as oral solution” NCT00002329